Advertisement

Side-Effects of Anti-Inflammatory Drugs

Part One Clinical and Epidemiological Aspects

  • K. D. Rainsford
  • G. P. Velo

Part of the Inflammation and Drug Therapy Series book series (IDTH, volume 1)

Table of contents

  1. Front Matter
    Pages i-xxv
  2. Clinical and Epidemiological Aspects

    1. Front Matter
      Pages 1-1
    2. T. K. Kvien, H. M. Høyeraal, B. Sandstad, E. Kåss
      Pages 125-135
    3. S. Perry, P. Streete, G. N. Volans
      Pages 173-175
  3. Drug Interactions and Drug Metabolism

    1. Front Matter
      Pages 177-177
    2. G. P. Velo, P. Minuz, E. Arosio, M. G. Capuzzo, G. Covi, A. Lechi
      Pages 195-201
    3. F. Sörgel, R. Koob, M. Hemmerlein, J. Braun, E. Lang
      Pages 203-215
    4. W. F. Kean, H. Howard-Lock, G. Caille, J. Bourgouin, J. Gauthier, J. A. Rischke et al.
      Pages 275-276
    5. P. J. Meffin, B. C. Sallustio, Y. J. Purdie, M. E. Jones
      Pages 281-282
  4. Gastrointestinal Tract (Clinical Aspects)

    1. Front Matter
      Pages 283-283
    2. D. St. J. Collier, J. A. Pain
      Pages 285-293
    3. F. R. Vicary, P. J. M. George, K. H. Fok
      Pages 295-302
  5. Back Matter
    Pages 315-327

About this book

Introduction

These two volumes contain the proceedings of a 3 day international meeting held at the University of Cambidge and Queens' College Cambridge from 31st July to 2nd August 1985 on the Side-Effects of Anti-Inflammatory Analgesic Drugs. The first meeting was held in Verona, (Italy) in 1982 and the organisers felt that, with a number of recent developments including the withdrawal of a num­ ber of new anti-inflammatory drugs, and concern being expressed in the lay and specialist medical press and other media about the safety of these drugs, that it was appropriate to have a second such meeting. The meeting was attended by some 300 delegates and the dis­ cussion focussed most intently on the recent issues, e. g. the value of adverse drug reaction reporting of the non-steroidal anti­ inflammatory (NSAI) drugs, certain side-effects associated with particular NSAI drugs, the predictive value of animal models etc. Organising a meeting de novo without outside help would not have been possible without the immensely valuable help given en­ thusiastically by people and financial assistance given most generously by those pharmaceutical companies listed below. These financial contributions were given despite current economic dif­ ficulties and moves to restrict the proportion of profits towards educational activities.

Keywords

Arthritis drug inflammation metabolism pharmacokinetics pharmacology rheumatoid arthritis toxicology

Editors and affiliations

  • K. D. Rainsford
    • 1
    • 2
  • G. P. Velo
    • 3
  1. 1.Department of PharmacologyUniversity of CambridgeCambridgeUK
  2. 2.Strangeways Research LaboratoryCambridgeUK
  3. 3.Institute of PharmacologyUniversity of VeronaVeronaItaly

Bibliographic information

  • DOI https://doi.org/10.1007/978-94-010-9772-7
  • Copyright Information Springer Science+Business Media B.V. 1987
  • Publisher Name Springer, Dordrecht
  • eBook Packages Springer Book Archive
  • Print ISBN 978-94-010-9774-1
  • Online ISBN 978-94-010-9772-7
  • Series Print ISSN 0923-9405
  • Buy this book on publisher's site